BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 25179300)

  • 1. Nanoluciferase as a novel quantitative protein fusion tag: Application for overexpression and bioluminescent receptor-binding assays of human leukemia inhibitory factor.
    He SX; Song G; Shi JP; Guo YQ; Guo ZY
    Biochimie; 2014 Nov; 106():140-8. PubMed ID: 25179300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quick preparation of nanoluciferase-based tracers for novel bioluminescent receptor-binding assays of protein hormones: Using erythropoietin as a model.
    Song G; Wu QP; Xu T; Liu YL; Xu ZG; Zhang SF; Guo ZY
    J Photochem Photobiol B; 2015 Dec; 153():311-6. PubMed ID: 26506452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel ultrasensitive bioluminescent receptor-binding assay of INSL3 through chemical conjugation with nanoluciferase.
    Zhang L; Song G; Xu T; Wu QP; Shao XX; Liu YL; Xu ZG; Guo ZY
    Biochimie; 2013 Dec; 95(12):2454-9. PubMed ID: 24056075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel inhibitors for murine and human leukemia inhibitory factor based on fused soluble receptors.
    Metz S; Naeth G; Heinrich PC; Müller-Newen G
    J Biol Chem; 2008 Mar; 283(10):5985-95. PubMed ID: 18174171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative measurement of cell membrane receptor internalization by the nanoluciferase reporter: Using the G protein-coupled receptor RXFP3 as a model.
    Liu Y; Song G; Shao XX; Liu YL; Guo ZY
    Biochim Biophys Acta; 2015 Feb; 1848(2):688-94. PubMed ID: 25434927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel bioluminescent receptor-binding assays for peptide hormones: using ghrelin as a model.
    Liu Y; Shao XX; Zhang L; Song G; Liu YL; Xu ZG; Guo ZY
    Amino Acids; 2015 Oct; 47(10):2237-43. PubMed ID: 26002812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LacdiNAc (GalNAcβ1-4GlcNAc) contributes to self-renewal of mouse embryonic stem cells by regulating leukemia inhibitory factor/STAT3 signaling.
    Sasaki N; Shinomi M; Hirano K; Ui-Tei K; Nishihara S
    Stem Cells; 2011 Apr; 29(4):641-50. PubMed ID: 21305673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid preparation of bioluminescent tracers for relaxin family peptides using sortase-catalysed ligation.
    Wang JH; Shao XX; Hu MJ; Wei D; Nie WH; Liu YL; Xu ZG; Guo ZY
    Amino Acids; 2017 Sep; 49(9):1611-1617. PubMed ID: 28631012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free LIF receptor α-chain distal cytoplasmic motifs enhance Jak2-independent STAT3 phosphorylation and induce differentiation in HL-60 cells.
    Sun Q; Wang J; Xiong J; Yang L; Liu H
    Oncol Rep; 2011 Aug; 26(2):399-404. PubMed ID: 21567092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioluminescent Ligand-Receptor Binding Assays for Protein or Peptide Hormones.
    Liu YL; Guo ZY
    Methods Mol Biol; 2016; 1461():65-90. PubMed ID: 27424896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of cytokine signaling through leukemia inhibitory factor receptor (LIFR)/gp130 attenuates ischemic brain injury in rats.
    Suzuki S; Yamashita T; Tanaka K; Hattori H; Sawamoto K; Okano H; Suzuki N
    J Cereb Blood Flow Metab; 2005 Jun; 25(6):685-93. PubMed ID: 15716858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for heterodimeric association of leukemia inhibitory factor (LIF) receptor and gp130 in the mouse uterus for LIF signaling during blastocyst implantation.
    Song H; Lim H
    Reproduction; 2006 Feb; 131(2):341-9. PubMed ID: 16452727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A family of leukemia inhibitory factor-binding peptides that can act as antagonists when conjugated to poly(ethylene glycol).
    Fairlie WD; Uboldi AD; Hemmings GJ; Smith BJ; Martin HM; Morgan PO; Baca M
    Biochemistry; 2003 Nov; 42(45):13193-201. PubMed ID: 14609330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex.
    Aasland D; Oppmann B; Grötzinger J; Rose-John S; Kallen KJ
    J Mol Biol; 2002 Jan; 315(4):637-46. PubMed ID: 11812136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukemia inhibitory factor: a paracrine mediator of bone metabolism.
    Sims NA; Johnson RW
    Growth Factors; 2012 Apr; 30(2):76-87. PubMed ID: 22304408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LIF receptor-gp130 interaction investigated by homology modeling: implications for LIF binding.
    Smith DK; Treutlein HR
    Protein Sci; 1998 Apr; 7(4):886-96. PubMed ID: 9568895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation.
    Adrian-Segarra JM; Schindler N; Gajawada P; Lörchner H; Braun T; Pöling J
    J Biol Chem; 2018 May; 293(18):7017-7029. PubMed ID: 29511087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of leukemia inhibitory factor (LIF), LIFR, gp130, and IL11 in the embryo implantation site of rat model with prenatal androgen-induced polycystic ovary syndrome.
    Javidan M; Changaei M; Ramezani Tehrani F; Mosaffa N; Noroozzadeh M; Hosseinzadeh R; Rajaei S
    Biochem Biophys Res Commun; 2022 May; 605():24-30. PubMed ID: 35306361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposing Roles of Acetylation and Phosphorylation in LIFR-Dependent Self-Renewal Growth Signaling in Mouse Embryonic Stem Cells.
    Wang XJ; Qiao Y; Xiao MM; Wang L; Chen J; Lv W; Xu L; Li Y; Wang Y; Tan MD; Huang C; Li J; Zhao TC; Hou Z; Jing N; Chin YE
    Cell Rep; 2017 Jan; 18(4):933-946. PubMed ID: 28122243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered interleukin-6-derived cytokines recruit artificial receptor complexes and disclose CNTF signaling via the OSMR.
    Rafii P; Cruz PR; Ettich J; Seibel C; Padrini G; Wittich C; Lang A; Petzsch P; Köhrer K; Moll JM; Floss DM; Scheller J
    J Biol Chem; 2024 May; 300(5):107251. PubMed ID: 38569939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.